Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16843425 | 0.83 | ALDH1A1 (0.47) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL17854771 | 0.80 | PABPC1 (0.39) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL24204859 | 0.80 | ALDH1A1 (0.34) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL17854794 | 0.77 | LPAR1 (0.37) | PABPC1CTDSP1LMNAPOLB | |
| SCHEMBL9610785 | 0.76 | PABPC1 (0.40) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL9610791 | 0.76 | PABPC1 (0.36) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL25714334 | 0.76 | CTDSP1 (0.44) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL9610773 | 0.75 | PABPC1 (0.38) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL13641643 | 0.75 | CTDSP1 (0.39) | PABPC1CTDSP1GAAADRA1DHTR1A | |
| SCHEMBL9610786 | 0.75 | PABPC1 (0.42) | PABPC1CTDSP1GAAADRA1DHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240019779-A1 | COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240019779-A1 | COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME | CRY1, CCNT1, CCNA1 | PABPC1 971/4885CTDSP1 2835/4885GAA 3580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.